Legacy Medical Consultants, a leading provider of allografts for the treatment of hard-to-heal chronic wounds, today announced the initiation of the REBOUND clinical trial: a prospective, post-market ...
Oncology experts from all over the world will discuss the latest developments in care. The American Society of Clinical ...
The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.
Verekitug led to statistically significant and clinically meaningful improvement in asthma symptom control as measured by the ...
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that new 48-week data from the IMPACT Phase 2b ...
Data from randomized, double-blind study in 226 adults to be presented as an oral abstractCLEVELAND, May 26, 2026 (GLOBE NEWSWIRE) -- Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical ...
An 8-month low-calorie diet plus behavioral support helped older adults with overweight or obesity and persistent atrial ...
BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that the last ...
Background Hearing loss (HL) imposes a substantial burden on families and society and is the largest modifiable risk factor ...
aTyr Pharma (NASDAQ:ATYR) said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after receiving feedback from the U.S. Food and Drug Administration at a recent Type C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results